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Abstract
Echocardiography is currently a widely available imaging technique that can
provide useful data in the field of sports cardiology particularly in two areas:
pre-participation screening and analysis of the cardiac adaptation induced by
exercise.
The application of pre-participation screening and especially, the type and
number of used diagnostic tests remains controversial. Echocardiography has
shown though, higher sensitivity and specificity as compared to the ECG,
following a protocol adapted to athletes focused on ruling out the causes of
sudden death and the most common disorders in this population. It is still a
subject of controversy the actual cost of adding it, but depending on the type of
sport, echocardiography might be cost-effective if added in the first line of
examination.
Regarding the evaluation of cardiac adaptation to training in athletes,
 echocardiography has proved to be useful in the differential diagnosis of
diseases that can cause sudden death, analysing both the left ventricle
(hypertrophy cardiomyopathy, dilated cardiomyopathy, left ventricle non
compaction) and the right ventricle (arrhythmogenic right ventricular
cardiomyopathy).
The aim of this paper is to review the current knowledge and the clinical
practical implications of it on the field of echocardiography when applied in
sport cardiology areas.
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Contributions of echocardiography in athletes
The number of people practicing sport has increased about five fold 
over the past 30 years1. The benefits of sport practice in improving 
cardiovascular health are unquestionable2, but an increase in cardio-
vascular events has also been demonstrated during its practice3. As 
a consequence, the absolute number of people at risk of sudden car-
diac death (SCD) during exercise is also increasing4. Sports activity 
is not a cause of the increased mortality per se; rather, it might act 
as a trigger of cardiac arrest in athletes with structural or electrical 
heart abnormalities that generating malignant arrhythmias. Thus, 
it seems reasonable that every effort should be made for early rec-
ognition of any disease that may put the athlete at risk, keeping in 
mind the perspective that inadequate disqualification of individuals 
might also pose a risk.
Therefore, a pre-participation screening (PPS) protocol seems to 
be of interest. Consequently, the European Society of Cardiology5 
has proposed an exam which emphasizes three points or steps: 
a) family and personal history, b) physical examination and 
c) 12-lead electrocardiogram (ECG). The ECG has demonstrated a 
70% sensitivity to detect the most frequent causes of SCD in young 
athletes6,7. However, about a third of these athletes with an anoma-
lous origin of coronary arteries, aortic diseases and incipient forms 
of cardiomyopathies will present with a normal ECG.
The echocardiogram might be a useful, non-invasive and accessible 
tool to increase sensitivity of screening8. Our group reported the 
echocardiographic findings among 2688 competitive athletes; most 
of the echocardiographic evaluations were normal and only 203 
(7.5%) showed abnormalities9. Cessation of athletic activity was 
indicated in 4 athletes: 2 for hypertrophic cardiomyopathy (elec-
trocardiography had shown changes that did not meet diagnostic 
criteria), 1 pectus excavatum with compression of the right ven-
tricle, and 1 significant pulmonary valve stenosis; the other minor 
alterations in echocardiography (7.5% of the total population) did 
not entail cessation of athletic activity and only indicated periodic 
monitoring.
Although rare, some cardiac structural changes can be missed on 
physical examination and electrocardiography; in contrast, they are 
easily recognized with echocardiography. These findings suggest 
the use of echocardiography in at least the first PPS of competitive 
athletes to improve the effectiveness of programs aimed at prevent-
ing SCD in athletes.
Currently, there is no consensus on what kind of echo scan has to 
be included in the PPS in order to detect the most prevalent cardiac 
abnormalities related to SCD. Some studies have suggested a quick 
5 minute echocardiogram protocol10 while other studies have pro-
posed longer protocols performing a complete echocardiogram11. 
In our group, we carry out the standard transthoracic echocardio-
graphic views suggested by the European Society of Echocardiog-
raphy12; we consider that the long-axis parasternal, the short-axis 
parasternal, the apical 4-chamber views and 2-chamber views, 
suprasternal and parasternal right view provide a high sensitivity to 
diagnose the most prevalent causes of SCD (summarized in Table 1).
Table 1. Echocardiographic scan protocol.
View Focus in …
LV Parasternal long-axis view 
(2D + M-mode + colour Doppler)
• LV hypertrophy or dilatation 
• Aortic and Mitral morphology and function 
• Aortic root (Marfan) 
• Ascending aorta (Marfan)
Parasternal short-axis view at 
aortic valve level 
(2D + colour Doppler)
• Coronary artery origin 
• Aortic valve morphology 
• Pulmonary valve 
• Atrial septum 
• Ventricular septum 
• Persistent Ductus 
• LV hypertrophy 
• LV non-compaction
Parasternal right view • RV morphology and function
Apical 4-chamber view 
(2D + colour Doppler + CW 
aortic)
• LV function 
• RV morphology and function 
• Aortic, mitral, and tricuspid valves morphology and function 
• Atrial and ventricular septum 
• Pulmonary veins
Suprasternal view • Aortic arch 
• Arterial Ductus
Subcostal view • RV morphology and function 
• Atrial septum 
• Ventricular septum
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The most common abnormalities detected in athlete’s echocardio-
grams can be divided into two different groups: physiological struc-
tural and functional cardiac adaptive changes that result in what is 
called the athlete’s heart, and echocardiographic signs of different 
cardiomyopathies that can induce SCD (Table 2).
Usefulness of echocardiography in pre-participation 
screening
To evaluate the cost effectiveness of the addition of a complemen-
tary study to the standard PPS, we have to take into account three 
basic parameters: a) incidence of SCD related to sport practice in 
the population b) cost of the study; c) years of potential life saved.
To date, there is no consensus which is the real incidence of SCD 
related to sports practice, because it depends on the analyzed popu-
lation. Studies in Italy22 and Israel23 have reported an incidence of 
2 cases of sudden death per 100,000 athletes per year, while other 
studies in France have documented an incidence of < 1 per 100,000 
athletes4. On the other hand, the cost to perform an echocardiog-
raphy is significantly different between American countries7 and 
Europe24. Finally, the quantification of the years of potential life 
lost depends on which population is considered, from school age25 
or all young adults up to master athletes engaged in sports26. The 
weight of each of these three factors (incidence of SCD, cost of 
studies, years of life saved) in a given population to determine the 
cost-effectiveness of adding echocardiography in PPS represent the 
challenge that we will have to face in the upcoming years.
Currently, it is still controversial if the inclusion of an ECG in the 
regular PPS is cost effective27 in the USA, while in Europe this 
recommendation was established more than 10 years ago5 and it 
has been adopted by the different sport committees28 and interna-
tional federations29. Several studies have demonstrated the cost-
effectiveness of including an ECG in the PPS7,30, but to date, only 
a small population study in school-aged athletes has analyzed the 
cost-effectiveness of adding an echocardiography in the screening31; 
the study showed that adding echocardiography increased both the 
cost and the sensitivity. In our opinion, the echocardiography pro-
vides a higher sensitivity of the PPS, especially in some special 
populations with greater amount of cardiac disorders described 
such as competitive athletes9, sports with high static component32 or 
long distance endurance athletes33. Recommendations for PPS and 
use of echocardiography used by our group according to the level of 
sport practice and training are summarized in Table 3.
Differentiating physiologic adaptation from 
pathology
The structural and functional adaptive changes that the heart devel-
ops in response to exercise, classically called “athlete’s heart“, has 
intrigued clinicians and scientists for more than a century. In the 
19th century, Henschen described for the first time sport induced 
cardiac enlargement by auscultation and percussion34. Seventy 
years after the first athlete’s electrocardiographic features were 
described35,36 and a few years after the first 2-dimensional echocar-
diography images showed the characteristic chamber enlarge-
ment and myocardial hypertrophy of the athlete’s heart. Finally, 
the current advanced echocardiography techniques and magnetic 
resonance imaging (MRI) have begun to clarify the mechanism 
involved in these athlete’s heart adaptive features. The study of the 
athlete’s heart is thus essential, not only to understand how car-
diac adaptation contributes to improved athletic performance, but 
also to differentiate the athlete’s heart from important disease states 
which may share similar morphologic features. We briefly review 
the physiologic and morphologic features associated with athletic 
training and the keys to differentiate normal adaptive athlete’s heart 
Table 2. Echocardiographic findings in athletes.
Athlete’s Heart • Ventricular dilatation and hypertrophy 
• Atrial dilatation 
• Ventricular hypertrabeculation 
• Mild aortic dilatation
Sudden Cardiac 
Death
Most common: 
• Hypertrophic cardiomyopathy 
• Anomalous origin of coronary artery 
 
Less common: 
• Aortic dilatation (Marfan) 
• Myocarditis 
• Mitral valve prolapse 
 
Uncommon: 
• Arrhytmogenic RV cardiomiopathy 
• Atherosclerotic coronary artery diseases 
• Aortic valve stenosis
Hypertrophic cardiomyopathy constitutes the leading cause of SCD 
in young athletes13. The ECG has demonstrated a high sensitivity in 
the diagnosis of this entity, but there is still around 10% of patients 
with hypertrophic cardiomyopathy, who have abnormal ECGs14–16. 
On the other hand, 9% of the athletes with mild adaptive left ven-
tricular (LV) hypertrophy show pathological changes in the ECG17. 
In both situations an echo scan would help to achieve the correct 
diagnosis.
The anomalous origin of the coronary arteries was considered 
to be a rare cause of SCD in athletes, but nowadays it has been 
demonstrated that it can be related to up to half of the previously 
asymptomatic SCD cases15. It was the second cause of sudden death 
associated with sports in the largest register of SCD in athletes13. 
The resting ECG of these athletes is normal, so this entity, if asymp-
tomatic, cannot be detected in a regular PPS based on anamnesis, 
physical examination and ECG. It is known that an echocardiogram 
performed by physicians with adequate training can differentiate 
coronary anomalies with high sensitivity18, and therefore echo is 
again a key tool to unmask these asymptomatic patients.
Aortic root diseases are an infrequent cause of SCD in young 
people17, although they seem to be a more prevalent cause of SCD 
in athletes19. Echocardiogram allows for the diagnosis as well as the 
follow up of these patients. Similarly, bicuspid aortic valve with-
out significant functional abnormalities would not be diagnosed in 
a regular PPS, and again, the echocardiogram would allow for an 
early diagnosis and a proper follow up20.
Finally, an echo scan is recommended in congenital heart disease 
patients, with special focus on ventricular morphology and func-
tion, pulmonary pressure and aortic diameters before starting an 
exercise protocol21.
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features from mild or initial expression forms of cardiac diseases 
such as hypertrophy cardiomyopathy (HCM), dilated cardiomy-
opathy (DCM), left ventricle non compaction (LVNC) and arrhyth-
mogenic right ventricular cardiomyopathy (ARVC).
Factors influencing cardiac remodeling in athletes
Different forms of exercise impose different loads on the cardiovas-
cular system. Classically, two forms have been described accord-
ing to their hemodynamic effect. Endurance exercise results in an 
increased cardiac output due to the rise in heart rate and stroke 
volume, reduced peripheral resistance and moderate increment 
in systemic blood pressure, leading to a volume overload. On the 
other hand, strength exercise is characterized by a maintained or a 
slightly increased cardiac output and peripheral vascular resistance, 
which results in increased blood pressure and thus an increased LV 
afterload. Cycling or running are examples of endurance exercise 
while weightlifting is an example of strength exercise, but there are 
also overlapped sports combining endurance and strength hemody-
namic conditions in different proportions such as soccer or hockey. 
These different hemodynamic conditions will result in different car-
diac adaptive structural and functional changes. Moreover, cardiac 
remodeling is not a continuous response to exercise; it is influenced 
by individual genetic factors, gender and race. Thus, a proper ath-
lete’s evaluation should be individual and take into account these 
potential influencers.
The left ventricle
Endurance exercise LV remodeling is typically described as LV 
chamber enlargement with increased wall thickness resulting in an 
eccentric LV hypertrophy, while strength remodeling is described as 
a thickening of the LV wall with a slight increase in the size of the 
LV cavity resulting in a concentric hypertrophy. This dichotomous 
view, first described by Morganroth et al.37 is currently controver-
sial. A meta-analysis by Pluim et al.38 initially confirmed this model; 
in contrast, a recent meta-analysis by Utomi et al.33 did not find this 
classic concentric remodeling in strength athletes and only found a 
slight LV dilatation and similar LV wall thickness as in endurance 
athletes. An increase in LV wall thickness is a typical feature of the 
athlete’s heart, however it is usually minimal and within normal 
range. In a cohort of 947 elite athletes Pelliccia et al.39 found a LV 
wall thickness > than 13 mm in only 1.7% of the athletes. Sharma 
et al.40 in a cohort of 720 elite athletes also reported a low incidence 
with only 0.4% of subjects showing LV wall thickness > 12 mm 
among elite junior athletes. However, this small number of extreme 
cases of exercise-induced remodeling may be difficult to differ-
entiate from mild forms of hypertrophic cardiomyopathy. Various 
studies have tried to find out the key to differentiate these two enti-
ties, but to date there is no pathognomonic sign available, and a 
combination of clinical and family history, electrocardiographic 
and echocardiographic features is recommended. The increase in 
LV wall thickness in athletes is an adaptation to increase stroke vol-
ume so it has to be accompanied by chamber enlargement. Thus, a 
LV end-diastolic diameter > 54 mm41, an increased LV volume and 
particularly LV volume/mass ratios by MRI42 have been proposed 
to differentiate athlete’s heart from disease41.
Recent advances in echocardiographic techniques including Tis-
sue Doppler Imaging (TDI) and Speckle Tracking Imaging (STI) 
permit an accurate assessment of the myocardial function, helping 
us to differentiate adaptation from disease. Numerous studies have 
demonstrated normal or even supranormal diastolic LV function in 
athletes43; instead, the pathological forms of LV hypertrophy are 
typically associated with an impaired diastolic dysfunction char-
acterized by lower early diastolic mitral annulus velocity44. Thus, 
the evaluation of diastolic LV function by TDI is nowadays manda-
tory in the evaluation of LV hypertrophy16. Figure 1 illustrates this 
echocardiographic differential diagnosis. In cases where differen-
tial diagnosis is unclear, MRI is useful. MRI offers a more accurate 
assessment of LV wall thickness, cardiac volumes, and tissue com-
position. Furthermore, adding gadolinium for late enhancement, the 
presence and location of myocardial fibrosis can be determined.
As previously described, LV cavity enlargement is part of the car-
diac remodeling observed in response to exercise, but this LV dila-
tation is in most cases minimal and indexed LV cavity dimensions 
are below pathologic limits. However, in the selected population 
of endurance elite-athletes this LV remodeling can be extreme. In 
a study by Pelliccia et al.45 more than 10% of elite ultra-endurance 
athletes had LV cavity end-diastolic dimensions > 60 mm, simulat-
ing forms of DCM. LV systolic function is described to be in a 
normal range among athletes46, but again, studies including high 
intensity endurance athletes have revealed a slight LV systolic 
dysfunction with LV ejection fraction around 45–49%47. In these 
extreme cases, the new advanced echocardiographic techniques 
can also help us. Although slightly lower ejection fraction of the 
LV might be found, the adaptive cardiac remodeling shows normal 
or even supranormal values of strain and strain rate by TDI, and 
normal values of longitudinal strain assessed by STI48. In contrast, 
in DCM patients these values are reduced49. The effect of endur-
ance training on ventricular deformation, torsion and untwisting 
rate needs further investigation, but promising findings report exer-
cise-induced supranormal LV untwisting rates50, confirming again 
the physiological LV response to exercise.
Finally, parallel to the improvement in echocardiographic tech-
niques and image resolution, a surprising high prevalence of LV 
Table 3. Cardiovascular pre-screening protocols according to the level of sport practice32. 
F&P: family and personal, PE: physical exam.
History F&P + PE ECG Echocardiography
Recreational sports Yes Yes No
Competitive athletes, High static and dynamic 
component Endurance training, > 10 hours/week Yes Yes Yes
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hypertrabeculation has been described in athletes. Gati et al.51 in 
a cohort of 1146 athletes studied by echocardiography, reported 
trabeculations in 20% of the athletes, and even more, around 8% 
fulfilled conventional criteria for the diagnosis of LV non-compaction 
cardiomyopathy; this prevalence raised to 13% when only black 
athletes were considered. LV non-compaction cardiomyopathy is 
a rare cardiomyopathy thought to be secondary to the arrest of nor-
mal myocardial development, resulting in multiple deep ventricu-
lar trabeculations52. This entity has a wide clinical expression from 
asymptomatic patients to advanced cases with three characteristic 
symptoms: heart failure, thromboembolic events and fatal arrhyth-
mias53, and has indeed been related to exercise-related SCD in 
young athletes54. The mechanisms implicated in LV hypertrabecu-
lation in athletes are still unknown, but the reported high prevalence 
suggests that it might be another expression of cardiac adapta-
tion to increased preload and afterload influenced by genetic and 
ethnical factors51. Structural echocardiographic features that could 
help to differentiate cardiac adaptive remodeling from disease are: 
the location of trabeculations (apical region in LV non-compaction 
cardiomyopathy versus mid-cavity region in athletes) and the evi-
dence of late enhancement in cardiac MRI following gadolinium 
in LV non-compaction cardiomyopathy54. Furthermore, LV non-
compaction cardiomyopathy patients may have reduced systolic 
and diastolic function while athletes with LV hypertrabeculation 
normally have no systolic or diastolic dysfunction. In the few cases 
with slightly low LV ejection fraction, a normal or even supranor-
mal increase in LV systolic function with exercise could help us to 
distinguish pathology from physiological adaptation51.
The right ventricle
During exercise, both ventricles have to increase stroke volume in 
response to the increased cardiac output demanded during exercise. 
This workload imposes high stress to all myocardial structures, 
which seems to be especially important in the right ventricle (RV) 
that typically works at low pressures in physiological conditions55. 
Classically, the study of the athlete’s heart was focused on the LV; but 
in the last two decades, with the introduction of advanced echocar-
diographic techniques and MRI, the RV exercise-remodeling has 
Figure 1. Echocardiographic assessment of an athlete with left ventricular hypertrophic adaptation (Figure 1: A, B, C) and a patient 
with a mild form of hypertrophic cardiomyopathy (Figure 1: D, E, F). Patients with hypertrophic cardiomyopathy present smaller LV end-
diastolic diameters, reduced radial strain values and reduced velocities of the mitral annulus as compared to athletes.
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started to be described. Structurally, endurance exercise has been 
related to RV enlargement, typically balanced with LV dilatation56. 
Functionally, high intensity endurance exercise has been related to 
lower global RV peak systolic longitudinal strain values at rest as 
compared to controls; the RV basal is the segment most affected 
in this change57. To date, whether these lower strain values are the 
result of myocardial damage58 or are only an adaptive response dem-
onstrated by an increased reserve after exercise provocation59 is still 
controversial. So far, few studies have focused on the RV in strength 
athletes but such RV remodeling seems to be less pronounced60. 
Extreme RV remodeling cases in elite ultra-endurance athletes 
may be indistinguishable from arrhythmogenic right ventricular 
dysplasia (ARVD). ARVD is a desmosomal cardiomyopathy char-
acterized by progressive adipose and fibrosis myocardial infiltra-
tion with potential bad prognosis and constitutes one of the most 
important causes of sudden death in young athletes13. Various stud-
ies have demonstrated more rapid disease progression in patients 
that practice moderate-high intensity exercise, making the differen-
tial diagnosis between disease and cardiac remodeling even more 
challenging61. As previously mentioned, endurance exercise can 
induce adaptive physiologic biventricular dilatation, where the ratio 
of LV/RV remains unchanged. On the other hand, a reduced LV/RV 
ratio could be a warning sign of underlying disease62. In addition, 
athlete’s RV remodeling has proved to be global as opposed to that 
observed in ARVD patients who show a disproportionate enlarge-
ment of the RV outflow tract. Functionally, no motion abnormalities 
have been described in athletes62 despite having a lower deformation 
in the basal segment of the RV; abnormal motion of the RV is essen-
tial data to fulfil the ARVD diagnostic criteria63. Figure 2 illustrates 
this echocardiographic differential diagnosis. Finally in doubtful 
cases, MRI can provide us an accurate structural and functional 
RV evaluation, distinguishing segments with dyskinesia, fibrosis 
or outflow tract microaneurysms64. However, to date, there is no 
single sign available to differentiate both entities and consequently, 
a combination of clinical and family history, electrocardiographic 
and echocardiographic features are recommended. Table 4 sum-
marizes the main echocardiographic features used to differentiate 
athlete’s heart from early stages of myocardial disease.
Figure 2. Echocardiographic assessment of an athlete with right ventricle remodelling (Figure 2: A, B, C); and a patient with 
arrhythmogenic right ventricular dysplasia in early stage (Figure 2: D, E, F). Patients with arrhythmogenic right ventricular dysplasia in 
early stage can present only mild RV dilatation but the relationship between LV and RV cavity tend to be less than 1 and the RVOT is at least 
mildly dilated and they present reduced RV global and segmental strain values as compared to athletes.
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Table 4. Echocardiographic features to differentiate athlete’s heart from 
cardiomyopathies. LV GLS: Left ventricle Global Longitudinal Strain.
Hypertrophy 
cardiomyopathy
Athlete’s heart
LV end-diastolic 
diameter
≤ 45mm > 54mm
LV volume/LV mass Reduced Normal
E´ mitral lateral annulus Reduced Normal or supranormal
LV radial and 
circumferential Strain Decreased Normal or supranormal
LV non compaction 
cardiomiopathy
Athlete’s heart
Trabeculation location Apical Mid-cavity
E´mitral lateral annulus Normal or reduced Normal or supranormal
LV GLS at rest 
LV GLS during effort
Normal or reduced 
Reduced
Normal or slightly reduced 
Normal or supranormal
Arrhythmogenic right 
ventricular dysplasia
Athlete’s heart
RV enlargement Early RVOT dilatation Global
Motion abnormalities Yes No
Ratio RV/LV volumes ≥ 1 < 1
Conclusions
In summary, echocardiography is a useful imaging tool to detect 
underlying heart disease that may imply a risk for people practic-
ing sport and at the same time is a non-expensive and non-invasive 
technique to evaluate cardiac adaptation to training. The challenge 
remains the diagnosis and differentiation of extreme adaptation to 
training that very much resembles early stages of some myocar-
dial diseases. Recently developed tools to better quantify cardiac 
performance have improved this issue but still more knowledge on 
the pathophysiology of cardiac adaptation to training is needed to 
optimize the identification of subjects at risk for sudden death or 
irreversible cardiac damage.
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Echocardiography is an informative method for examination of cardiac structures and not dispensable in
examination of athletes. Dr Grazioli focused his paper on analysis of left and right ventricle and did it well.
Right and left atrial dimensions  (and function ), aortic dimension   (and stiffness ) or pulmonary
dimensions and function  were not focused in this initial article of the sports cardiology channel because 
it is problematic to start with and to write a complete update with the burden of complete
echocardiographic potential/possibilities. In one of his own papers he described alterations of aortic
valve/pulmonary valve/mitral valve in athletes and aortic root dilatation or severe pulmonary stenosis .
Echocardiography was recommended for screening of athletes under different circumstances  and
particularly for follow up  examinations. The possibilities of strain echocardiography were discussed
in the past  and we look forward to new. The global longitudinal strain has better reproducibility , the
potential of radial strain seems to be limited in examination of training effects .  
 I recommend indexing of this article with the option to write an update with further possibilities and
importance of echocardiography in the examinations of atrial function/valve and aortic function including
3D echocardiography and the further analysis of recreational  athletes  and importance of follow-up
examinations . The advantage of this sports cardiology channel is the possibility for updating papers
with new literature and information and to actualize the growing knowledge in sports cardiology.
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 Flavio D'Ascenzi
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The paper by Grazioli and colleagues provides a comprehensive review on the current knowledge and the
clinical implications of echocardiography when applied to the evaluation of athlete’s heart in the context of
pre-participation screening. The paper is currently focused on right and left ventricles, is well written, and
analyses not only standard echocardiography, but also the novel echocardiographic techniques applied
to athlete’s heart, with a specific focus on the differential diagnosis between exercise-induced
physiological remodelling and the diseases most commonly cause of sudden cardiac death.
 
Major revisions
Although the clinical implications of biatrial analysis has to be understood, in my opinion a brief paragraph
on the analysis of biatrial morphology and function could be potentially of interest, also considering the
some authors have demonstrated its utility in the differential diagnosis between athlete’s heart and
cardiomyopathies.
 
An interesting point of using echocardiography in the context of a screening has not been analysed.
Although some authors debate about the utility and the costs of echocardiography, in my opinion the
fundamental question of the application of echocardiography to the pre-participation screening in athletes
is WHEN performing this exam. Considering that a frequent echocardiographic evaluation is not feasible
in low-risk populations and dramatically increases the cost in absence of real clinical advantages, one has
to suppose that one or two exams can be performed during the career of a non-professional athlete.
Although some congenital defects can be detected in the early phase of the life of an individual, some of
the most common cause of sudden cardiac death are the genetic myocardial diseases, such as HCM,
DCM, and ARVC, all known to have a delayed phenotype expression.  Thus, performing an
echocardiogram at the beginning of the athletic career of a child could detect congenital defects, but
could be misleading in excluding the cardiomyopathies most commonly associated with sudden cardiac
death, with a typical expression in the II-III (or even IV) decades of life of a young athlete. I think that the
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death, with a typical expression in the II-III (or even IV) decades of life of a young athlete. I think that the
authors should analyse this clinical question and should provide a personal opinion based on the current
available evidences and on the experience of their Center.
 
Minor revisions
In table 1 I think that “aortic coartation” should be included in the section “suprasternal view”.
 
Table 2: exercise has not proven to be a determinant of a physiological dilation of the aorta; conversely, it
has been demonstrated that aortic dimensions are comparable with those of the general population.
Accordingly, I suggest removing “mild aortic dilation” from table 2, section “athlete’s heart”.
 
Atherosclerotic coronary artery disease cannot be detected by echocardiography, although indirect signs
such as left ventricular wall motion abnormalities can suggest its presence. However,  considering the
signs are uncommonly observed in athletes, I suggest to remove “Atherosclerotic coronary artery
disease” from table 2, section “sudden cardiac death”.
 
Left ventricular non compaction: “it might be another expression of cardiac adaptation to increased
preload and afterload influenced by genetic and ethnical factor”: ref. #51 is not correct because does refer
to an hypothesis rather than an explanation of the phenomenon. I suggest to cite the article by Gati S. et al
(Circulation 2014) and the work by D’Ascenzi F.  (Int J Cardiol 2015) both explaining the physiological et al
determinants of benign hypertrabeculation in the athletes.
 
Table 3: the definition “competitive athletes, high static and dynamic component endurance training, > 10
hours/week” is not clear: which is the opinion of the authors? Although it is clear that echocardiography is
not recommended in subjects engaged in recreational sports, which are the athletes to be evaluated by
echocardiography? All the competitive athletes? Athletes with abnormal findings at resting ECG or at
history/physical examination? Athletes engaged in high-volume training programs?...Please specify.
 
Table 4
At the present time, LV circumferential and radial strains cannot be definitively suggested to distinguish
between cardiomyopathies and athlete’s heart. LV longitudinal strain is highly sensitive for myocardial
disorders and more reproducible than circumferential and radial strains ((Feigenbaum H, Circ J 2012).
Because of the LV shortens from base to apex in systole, the fixed short-axis tracking that is required for
circumferential and radial strain is more difficult than longitudinal tracking. Particularly, radial strain is
intrinsically more vulnerable to measurement variability because strain assessed in these orientations
represents an aggregate measure of endocardial, mesocardial and epicardial tissue motion,
encompassing both myocardial fiber shortening and global LV torsion in systole. The best inter- and
intra-observed reproducibility is observed for LV longitudinal strain and particularly data based on
measurements of LV radial strain should be interpreted with caution (Cheng S, J Am Soc Echocardiogr
2013). A limited reliability has been observed also for LV circumferential strain measurements. A possible
explanation is that circumferential deformation twist can hardly be assessed in the same view, because
the base descends to the apex. This movement makes the correct measurement in the short axis view
impossible in two different time-points or even in two different days.
Finally, LV longitudinal strain measurements are known to be more robust than radial ones (Mor-Avi, Eur J
Echocardiogr 2011). According to these considerations and to the fact that LV longitudinal strain is the
only form of strain that is used routinely (Feigenbaum H, Circ J 2012), I suggest to remove both radial and
circumferential strains from table 4 and to stress in the text that future studies are needed to evaluate
whether these deformation parameters could be used in the clinical practice.
 
“motion abnormalities” -> please correct with “wall motion abnormalities”
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“motion abnormalities” -> please correct with “wall motion abnormalities”
 
Table 4: according to the current available data on deformation analysis applied to the athlete’s heart, I
suggest to describe LV GLS at rest as “normal” and not “normal or slightly reduced”.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
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 Andreas Müssigbrodt
Department of Electrophysiology, University of Leipzig, Leipzig, Germany
This review summarizes some important aspects of echocardiography as a screening tool for the
screening of athletes and should therefore be of interest for sports physicians and cardiologists. The
potential advantages of this method and the technical aspects are well described.
I would nevertheless recommend to mention potential problems too, mainly overdiagnosis and
misdiagnosis with important consequences for the career of athletes and additional costs.  In order to
prevent overdiagnosis and misdiagnosis, intensive training of sports cardiologists seems to be of utmost
importance.
Furthermore, as research in this area often focuses on young, competitive athletes, I would recommend to
discuss the potential value of echocardiography for older, non-competitive, recreational athletes.
I recommend indexing after minor revision.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
Page 15 of 15
F1000Research 2015, 4:151 Last updated: 27 JUL 2015
